Technology
Health
Medical

Ekso Bionics

$2.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-2.46%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Ekso Bionics and other stocks, options, ETFs, and crypto commission-free!

About

Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. Read More The EksoHealth segment consists of the design, engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.

Employees
82
Headquarters
Richmond, California
Founded
2012
Market Cap
149.85M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
510.38K
High Today
$2.44
Low Today
$2.35
Open Price
$2.44
Volume
99.07K
52 Week High
$3.30
52 Week Low
$1.23

Collections

Technology
Health
Medical
Engineering
Healthcare
Medical Devices
Research And Development
2014 IPO

News

Seeking AlphaFeb 28

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q4 2018 Results - Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2018 Results Earnings Conference Call February 28, 2019 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Contact, Lazar Partners Jack Peurach - President and Chief Executive Officer Jack Glenn - Chief Financial Officer Conference Call Participants Bruce Nudell - SunTrust Robinson Humphrey Operator Greetings and welcome to the Ekso Bionics' Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-o...

1,267
MarketBeatFeb 27

Stock Price, News, & Analysis for Ekso Bionics

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, an...

105

Earnings

-$0.33
-$0.24
-$0.16
-$0.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 6, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.